Anti-amyloid therapy and cerebral blood flow changes on Magnetic Resonance Imaging: a potential longitudinal biomarker of treatment response?

Andres Ricaurte-Fajardo, Jana Ivanidze, Deborah Zhang, Meem Mahmud, Weiye Yasen, Lisa Ravdin, Silky Pahlajani, Mony de Leon, Anna S. Nordvig and Gloria C. Chiang

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Published online January 13, 2025.


Author Information

  1. Andres Ricaurte-Fajardo,
  2. Jana Ivanidze,
  3. Deborah Zhang,
  4. Meem Mahmud,
  5. Weiye Yasen,
  6. Lisa Ravdin,
  7. Silky Pahlajani,
  8. Mony de Leon,
  9. Anna S. Nordvig and
  10. Gloria C. Chiang
  1. From the Department of Department of Radiology, Brain Health Imaging Institute (A.R-F, J.I, S.P, M.d, G.C.C) Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York, USA; the Department of Neurology (A.R-F), Pontificia Universidad Javeriana, Bogota, Colombia; the Department of Radiology, Division of Molecular Imaging and Therapeutics (A.R-F, J.I) Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York, USA; the Department of Neurology (D.Z, MM, L.R, A.S.N) Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York, USA

Altmetrics

Cited By...

Advertisement